Loading...
Loading...
The following is by Galileo Russell, who primarily invests in momentum stocks and is currently in the process of starting a hedge fund focusing on emerging markets & high growth stocks.
With all the recent drama surrounding Dendreon (
DNDN) and their groundbreaking cancer drug Provenge, I believe it's time to uncover a very Dendreon like [...]
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: Markets
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in